CURRENT FUNDING OPPORTUNITIES

Early Phase Clinical Trials in Imaging and Image-Guided Interventions (R21)

PROGRAM ANNOUNCEMENT

PAR-11-216: http://grants.nih.gov/grants/guide/pa-files/PAR-11-216.html
(Expiration date: March 14, 2014)

Contacts:
Lalitha K. Shankar, M.D., Ph.D.
301-496-9531, shankarl@mail.nih.gov

Frank I. Lin, M.D.
301-451-2669, linfi@mail.nih.gov

This announcement is intended to support clinical trials conducting preliminary evaluation of the safety and efficacy of imaging agents, as well as an assessment of imaging systems, image processing, image-guided therapy, contrast kinetic modeling, and 3-D reconstruction and other quantitative tools. As many such preliminary evaluations are early in development, this program will provide investigators with support for pilot (phase 1 and 2) cancer imaging clinical trials, including patient monitoring and laboratory studies. The imaging and Image-guided Intervention (IGI) investigations, if proven successful in these early clinical trials, can then be validated in larger studies through competitive R01 mechanisms, or through clinical trials in the Specialized Programs of Research Excellence (SPOREs), Cancer Centers, and/or Cooperative Groups.